Agios Pharmaceuticals
AGIO
#5092
Rank
S$2.21 B
Marketcap
S$37.09
Share price
-3.10%
Change (1 day)
27.12%
Change (1 year)

Market capitalization of Agios Pharmaceuticals (AGIO)

Market cap: S$2.21 Billion

As of November 2026 Agios Pharmaceuticals has a market cap of S$2.21 Billion. This makes Agios Pharmaceuticals the world's 5092th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Agios Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.21 B5.74%
2025S$2.09 B-18.98%
2024S$2.58 B57.5%
2023S$1.64 B-20.52%
2022S$2.06 B-14.29%
2021S$2.41 B-39.21%
2020S$3.97 B-9.84%
2019S$4.40 B20.07%
2018S$3.66 B-1.63%
2017S$3.72 B46.91%
2016S$2.53 B-26.7%
2015S$3.46 B-36.97%
2014S$5.49 B480.1%
2013S$0.94 B

End of Day market cap according to different sources

On Nov 19th, 2026 the market cap of Agios Pharmaceuticals was reported to be:

S$2.21 Billion
by Nasdaq info icon info icon
S$2.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$202.43 B 9,025.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.552 T 69,866.02%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$123.61 B 5,472.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
S$3.29 B 48.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
S$20.71 B 833.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$15.34 B 591.62%๐Ÿ‡บ๐Ÿ‡ธ USA